Calidi Biotherapeutics (CLDI) Q1 2026 Earnings
CLDI·Reported May 14, 2026·Before market open
Diluted EPS came in at $-0.43 (+80.1% YoY).
Diluted EPS
$-0.43
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Calidi Biotherapeutics's Q1 2026 earnings report.
Calidi Biotherapeutics (CLDI) reported Q1 2026 earnings on May 14, 2026 before market open.
Calidi Biotherapeutics reported diluted EPS of $-0.43 for Q1 2026.
Compared to the same quarter a year prior, diluted EPS grew 80.1% from $-2.16.
You can read the 8-K earnings release (0001493152-26-023094) and the 10-Q periodic report (0001493152-26-023140) directly on SEC EDGAR. The filing index links above go to sec.gov.